During an implementation period of maximum two years, it will be permitted to sell released packs on which a UK marketing authorisation holder or a representative is indicted as well as packs on which an EEA marketing authorisation holder or a representative is indicated for the concerned D.Sp.No. (Danish speciality number).
28 September 2018Debate on research dissemination at the Danish Medicines Agency
28 September 2018Drug agency from China visits Denmark
20 September 2018Medicines of the future in focus at World Economic Forum